Literature DB >> 4694690

Comparative study of the absorption, plasma levels, and urinary excretion of the "new" and the "old" Lanoxin.

D Falch, A Teien, C J Bjerkelund.   

Abstract

A comparative study was performed of the absorption, the plasma level at equilibrium, and the urinary excretion of digoxin using two types of Lanoxin tablets, those produced before and after the 1972 alteration of the tablet manufacture.After a single dose the absorption rate of the new tablets was about twice as great as the old, both in young subjects and in the elderly patients. There were no significant differences in the plasma levels of digoxin for the two tablets 15 hours after the last administration in patients on an equal maintenance dose. The urinary excretion of digoxin increased about 40% when the "old" Lanoxin was replaced by the "new." In elderly patients a daily dose of 0.125 mg twice daily of the new tablets should be sufficient to reach the therapeutic range. Young people need a higher dosage. If the kidney function is reduced by as much as 50% the dose should be reduced.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4694690      PMCID: PMC1588819          DOI: 10.1136/bmj.1.5855.695

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  4 in total

1.  Variation in the biological availability of digoxin.

Authors:  T R Shaw; M R Howard; J Hamer
Journal:  Lancet       Date:  1972-08-12       Impact factor: 79.321

2.  Serum-digoxin concentrations during treatment with different preparations.

Authors:  V Manninen; J Melin; G Hartel
Journal:  Lancet       Date:  1971-10-23       Impact factor: 79.321

3.  Variation in biologic availability of digoxin from four preparations.

Authors:  J Lindenbaum; M H Mellow; M O Blackstone; V P Butler
Journal:  N Engl J Med       Date:  1971-12-09       Impact factor: 91.245

4.  Plasma concentrations of digoxin after oral administration in the fasting and postprandial ste.

Authors:  R J White; D A Chamberlain; M Howard; T W Smith
Journal:  Br Med J       Date:  1971-02-13
  4 in total
  10 in total

1.  [Comparison of digitoxin bioavailability from tablets and elixir during maintenance therapy (author's transl)].

Authors:  H Ochs; G Bodem; E Hahn; H J Dengler
Journal:  Klin Wochenschr       Date:  1975-05-01

2.  Proceedings: Cardiotoxicity and the plasma digoxin concentration profile in conscious dogs.

Authors:  D J Chapple; R Hughes; B F Johnson
Journal:  Br J Pharmacol       Date:  1975-06       Impact factor: 8.739

3.  Cardiovascular disease in the old.

Authors:  J Wedgwood
Journal:  Br Med J       Date:  1973-09-22

4.  Therapeutic non-equivalence of digoxin tablets in the United Kingdom: correlation with tablet dissolution rate.

Authors:  T R Shaw; K Raymond; M R Howard; J Hamer
Journal:  Br Med J       Date:  1973-12-29

5.  Bioavailability studies with Digoxin-Sandoz and Lanoxin.

Authors:  T Beveridge; F Kalberer; E Nüesch; R Schmidt
Journal:  Eur J Clin Pharmacol       Date:  1975-06-13       Impact factor: 2.953

6.  Biological availability of digoxin from Lanoxin produced in the United Kingdom.

Authors:  B F Johnson; A S Fowle; S Lader; J Fox; A D Munro-Faure
Journal:  Br Med J       Date:  1973-11-10

Review 7.  Clinical pharmacokinetics of digoxin.

Authors:  E Iisalo
Journal:  Clin Pharmacokinet       Date:  1977 Jan-Feb       Impact factor: 6.447

Review 8.  Bioavailability of drugs: the digoxin dilemma.

Authors:  D J Greenblatt; T W Smith; J Koch-Weser
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

9.  Recent changes in biological availability of digoxin. Effect of an alteration in 'Lanoxin' tablets.

Authors:  T R Shaw; M R Howard; J Hamer
Journal:  Br Heart J       Date:  1974-01

10.  The relationship between cardiotoxicity and plasma digoxin concentration in conscious dogs.

Authors:  D J Chapple; R Hughes; B F Johnson
Journal:  Br J Pharmacol       Date:  1976-05       Impact factor: 8.739

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.